Days-Off Versus Daily Initial Peritoneal Dialysis Prescription
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07922772. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Comparative Effectiveness of Days-Off Versus Daily Initial Peritoneal Dialysis Prescription
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare days-off (5 or 6 days a week) with daily (7 days a week) peritoneal dialysis (PD) in adults who are starting PD to treat kidney failure and make at least 16 ounces (two cups) of urine a day. Once enrolled, participants will be placed into one of two groups by chance, like flipping a coin: days-off PD or daily PD. Participants will be asked to stay on the assigned PD schedule (days-off or daily) for at least 6 months. After that, participants will continue this schedule for as long as it continues to be right for their health. Participants will be followed for as long as they remain on PD, up to 24 months. Most participants assigned to the days-off schedule will switch to daily PD at some point between 6 and 24 months because of further drop in urine output. Other than days per week, all parts of participant's PD prescription will be decided by their care team at their regular monthly PD clinic visits, just as if they were not in the study. Study visits will happen around the time of these regular clinic visits. No extra trips are required. Participants will be asked to complete surveys. Most other study data will be collected from the medical chart. No blood or biological samples will be taken for the study.
Study identification
- NCT ID
- NCT07922772
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 450 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2027 (Estimated)
- Primary completion
- Nov 2030 (Estimated)
- Completion
- Nov 2030 (Estimated)
- Last update posted
- Nov 6, 2026
2027 – 2030
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lundquist Institute at Harbor-UCLA Medical Center | Torrance | California | 90502 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Northwestern University | Evanston | Illinois | 60208 | — |
| University of Indiana | Bloomington | Indiana | 47405 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Rogosin Institute, Inc (New York-Presbyterian Hospital/Weill Cornell Medicine) | New York | New York | 10021 | — |
| Mount Sinai School of Medicine (MSSM) | New York | New York | 10029 | — |
| Wake Forest University School of Medicine (WFUSM) | Winston-Salem | North Carolina | 27109 | — |
| University of Texas Southwestern (UTSW) | Dallas | Texas | 75390 | — |
| University of Washington (UW) | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07922772, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 6, 2026 · Synced Nov 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.